Cargando…
Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease
Alzheimer’s disease (AD) is a severe neurodegenerative brain disorder. The determination of beta-amyloid (Aβ)-40, –42, total tau, and phospho-tau-181 (pTau181) in cerebrospinal fluid (CSF) using Lumipulse technology has been established as biomarkers for AD in recent years. As CSF collection is an i...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557075/ https://www.ncbi.nlm.nih.gov/pubmed/36247998 http://dx.doi.org/10.3389/fnagi.2022.1014305 |